Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Work In Process (2016 - 2025)

Historic Work In Process for Orthofix Medical (OFIX) over the last 15 years, with Q3 2025 value amounting to $61.0 million.

  • Orthofix Medical's Work In Process rose 38.2% to $61.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.0 million, marking a year-over-year increase of 38.2%. This contributed to the annual value of $56.9 million for FY2024, which is 637.26% up from last year.
  • Latest data reveals that Orthofix Medical reported Work In Process of $61.0 million as of Q3 2025, which was up 38.2% from $61.4 million recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's Work In Process peaked at $61.4 million during Q2 2025, and registered a low of $14.5 million during Q1 2022.
  • Moreover, its 5-year median value for Work In Process was $54.6 million (2023), whereas its average is $39.9 million.
  • Its Work In Process has fluctuated over the past 5 years, first crashed by 548.21% in 2022, then skyrocketed by 30389.58% in 2023.
  • Over the past 5 years, Orthofix Medical's Work In Process (Quarter) stood at $15.1 million in 2021, then rose by 27.47% to $19.2 million in 2022, then soared by 178.08% to $53.5 million in 2023, then rose by 6.37% to $56.9 million in 2024, then grew by 7.11% to $61.0 million in 2025.
  • Its Work In Process was $61.0 million in Q3 2025, compared to $61.4 million in Q2 2025 and $56.8 million in Q1 2025.